ORTEXORTEX News
Tracking MCRI? Get live short interest, options flow, and signals on ORTEX.Sign up free →
MC
Trader NoteMCRI

Monarch Steady After Earnings, but Analysts Hold Neutral

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 28 Oct 2026, 18:34

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

MCRI reported Q3 results on October 27 and the stock barely moved, closing at $115.28 with a loss of less than 1% on the day. The week's most interesting question is whether that muted reaction signals genuine stability or simply a lack of conviction in either direction.

The lending and positioning picture is about as relaxed as it gets. Short interest is 3.3% of the free float, down almost 6% on the week and broadly unchanged over the past month. Borrowing costs are low at 0.46%, though they did tick up from 0.16% on Monday, a small noise move rather than a signal. Availability is extraordinarily loose at more than 7,400%: there are roughly ten shares available to borrow for every one currently lent out, making this one of the least contested names in the lending market. The ORTEX short score has also been easing, drifting from around 40.8 in mid-October to 39.4 now, placing MCRI in the lower-to-mid tier of bearish pressure across the market. Options activity has picked up a touch, with the put/call ratio at 0.30 against a 20-day average of 0.13. The z-score is 1.4, modestly elevated but nowhere near alarming. That shift is likely earnings-related hedging that will fade quickly. Peer names PENN and RRR both edged lower on the week, down 0.9% and 1.0% respectively, while MCRI added 0.9%, a small but consistent pattern of relative resilience.

The Street is largely on the sidelines. The consensus leans cautious, with Macquarie, Wells Fargo and Stifel all maintaining hold-equivalent ratings. Macquarie's Chad Beynon trimmed his target to $125 from $128 on October 7, the most recent move, though the mean target across coverage sits at $125.67. At a current price of $115.28, that implies roughly 9% upside, which sounds reasonable until you note that nobody has yet pulled the trigger on a Buy. The bull case centres on MCRI's two-property model, the Atlantis in Reno and the Black Hawk casino in Colorado, both of which have benefited from renovation-driven demand. Q2 net revenue reached $142.6 million and adjusted EBITDA $53.0 million, beating expectations, and the balance sheet carries $120 million in cash with no drawings on the credit facility. Bears point to Reno promotional intensity, potential California tribal competition cutting into drive-to traffic, and the possibility that wage inflation continues to squeeze margins. Valuation is modest, with the stock trading at roughly 16.8 times earnings and 9.2 times EV/EBITDA, both slightly lower than a month ago. The dividend score ranks in the 94th percentile, reflecting an unusually consistent payout track record for a regional gaming operator.

Ownership concentration is one of the more distinctive features of this company. The Farahi family collectively holds north of 32% of shares outstanding, with CEO John Farahi at 17.5%, Ben Farahi at 8.4% and Bahram Farahi at 6.5%. BlackRock has been adding, lifting its reported stake to 11.5% as of September. T. Rowe Price made the most notable institutional move in recent months, adding roughly 253,000 shares to bring its holding to 322,561 shares. Against that backdrop, the only open-market insider transaction in the past 90 days was John Farahi selling 5,000 shares at $124 in September, a modest disposal worth $620,000 without a 10b5-1 plan attached. It is a small sale relative to his overall holding and does not represent a meaningful directional shift, but it is the only insider signal available.

Wikipedia attention for MCRI spiked to a z-score of 3.3 against its own 90-day history as of October 19, consistent with a burst of retail interest around the earnings release. There are no alt data datasets with a measured lead on MCRI's financials, so that attention reading is colour rather than a fundamental signal.

With Q3 results now digested and the next scheduled print not until February 3, the stock enters a quiet period. The main watch items are monthly visitation trends in Reno and Black Hawk, any commentary on California tribal competition, and whether the Street's cautious consensus shifts if the margin story continues to hold.

Stocks in this article

See the live data behind this article on ORTEX.

Open MCRI on ORTEX →

How this article was generated

Generated
28 Oct 2026, 18:37
Data as of
28 Oct 2026, 18:34
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.